BANIN, Eyal,REUBINOFF, Benjamin Eithan,BOHANA-KASHTAN, Osnat,NETZER, Nir,IRVING, Charles Sherard
申请号：
SG11201705378R
公开号：
SG11201705378RA
申请日:
2015.04.30
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
A method of treating a subject with dry-form age-related macular degeneration (AMD) is disclosed. The method comprises administering into the subretina of the subject a therapeutically effective amount of a pharmaceutical composition comprising human RPE cells, wherein at least 95% of the cells thereof co-express premelanosome protein (PMEL17) and cellular retinaldehyde binding protein (CRALBP), wherein the trans-epithelial electrical resistance of the cells is greater than 100 ohms to the subject, thereby treating the subject.
